Nose & Sinus Study Notes

Nose & Sinus Objectives

  • Overview of disorders associated with the nose and sinus

    • Nose disorders

    • Epistaxis

    • Nasal polyps

    • Rhinitis

    • Olfactory dysfunction

    • Sinusitis

    • Acute

    • Chronic

    • Neoplasms

Nasal Anatomy Review

  • Bony structures

    • Vomer

    • Ethmoid

    • Nasal bone

    • Palatine

    • Maxilla

  • Cartilaginous structures

    • Septal cartilage

    • Greater alar cartilage

    • Upper lateral cartilages

    • Minor alar cartilages

    • Lower lateral cartilage (major alar)

    • Lateral crux

    • Medial crux

    • Nasal septal cartilage: Bony components, Cartilage

    • Columella

Internal Nasal Structures

  • Internal nasal structure

    • Internal nasal valve: Lateral cartilage

    • External nasal valve: Head of inferior turbinate and nasal septum

    • Anatomy of sinuses

    • Frontal sinus

    • Sphenoid sinus

    • Ethmoid sinus

    • Maxillary sinus

Vascular Supply to the Nose

  • Key arteries

    • External nasal artery (from anterior ethmoidal artery)

    • Anterior & posterior ethmoidal arteries

    • Sphenopalatine artery

    • Kiesselbach's plexus (Little's area)

    • Woodruff's plexus

    • Alar branch of the lateral nasal artery

Olfactory Anatomy

  • Components of olfaction

    • Olfactory epithelium

    • Bowman's gland

    • Olfactory nerve fibres

    • Basal cell

    • Supporting cell

Olfactory Dysfunction

  • Anosmia

    • Prevalence: 12.4% of U.S. adults ≥40 years show olfactory dysfunction; 3.2% have anosmia/severe hyposmia

    • Impacts quality of life

    • Affects enjoyment of food and daily functions

    • Causes: nasal and paranasal sinus disease, post-viral olfactory dysfunction

    • Workup: Basic odorant tests (chocolate, coffee)

    • Imaging: MRI for trauma, neurologic concerns; CT for sinus disease

Treatment for Anosmia

  • Address underlying causes

  • Smell training—sniffing 4 odors (e.g., rose, lemon, clove, eucalyptus) for 10 seconds, twice daily for a minimum of 12 weeks

Rhinitis

  • Definition: Irritation and inflammation of the mucous membranes of the nose

  • Signs & Symptoms

    • Nasal congestion

    • Rhinorrhea

    • Nasal itching

    • Sneezing

    • Post-nasal drip

    • Cough, Anosmia/Hyposmia

Types of Rhinitis

  • Allergic Rhinitis

    • Seasonal or perennial

  • Nonallergic Rhinitis

    • Rhinitis medicamentosa

    • Chronic rhinitis

    • Polypous rhinitis

    • Infectious (viral, bacterial)

Acute Rhinitis Case Study

  • 28-year-old patient, Emilia Mendoza

    • Experiences chronic nasal congestion, sneezing, watery eyes, worsened by outdoor exposure

    • Past medical history: childhood asthma; currently urban apartment with pets

Allergic Rhinitis

  • Inflammation of nasal mucosa leading to paroxysms of sneezing, rhinorrhea, nasal obstruction

  • Causes: Environmental allergen exposure

  • Associated with: Atopy (asthma, allergic conjunctivitis, atopic dermatitis)

Signs & Symptoms of Allergic Rhinitis
  • Itchy, red, and watery eyes

  • Cobblestoning of pharynx

  • Strong family history

  • Sleep disturbances

Categorization
  • Temporal pattern: Seasonal, perennial

  • Frequency: Intermittent, persistent

  • Severity: Mild, severe

  • Common Allergens: Pollen, dust mites, molds, animal dander

Physical Examination
  • Findings may include pale, boggy mucosa, cobblestone mucosa

  • Rhinitis may cause nasal polyps over time

Management of Allergic Rhinitis
  • Environmental control measures: Avoid allergens, nasal saline spray

  • Pharmacotherapy:

    • Intranasal corticosteroids (e.g., fluticasone)

    • Use 1-2 sprays in each nostril twice daily

    • Antihistamines (oral/intranasal) providing rapid symptom relief

    • First-generation (e.g., diphenhydramine) more sedating

    • Second-generation (e.g., loratadine) less sedating

    • Decongestants: Pseudoephedrine, oxymetazoline (but beware of rebound congestion)

    • Additional options: Mast cell stabilizers, intranasal anticholinergics

Immunotherapy
  • Begins with identification of allergens

  • Dose response progression

  • Maintenance typically over 3-5 years

Nonallergic Rhinitis

  • NOT due to allergies; chronic symptoms of nasal congestion, rhinorrhea, and postnasal drainage

  • Triggers: Irritant odors, strong fragrances, temperature changes

  • Treatment strategies: Topical glucocorticoids, antihistamines, saline irrigation

Rhinitis Medicamentosa

  • Rebound nasal congestion from decongestant overuse

  • Treatment: Withdrawal of nasal spray, saline nasal sprays

Sinusitis

  • Inflammation of paranasal sinuses, often viral or from allergies

  • Types:

    • Acute (1-4 weeks)

    • Recurrent acute (4+ episodes/year)

    • Subacute (4-12 weeks)

    • Chronic (>12 weeks)

Diagnosis & Imaging
  • CT scans for uncertain diagnoses; X-ray (Water's view) for assessing sinus conditions

Acute Viral Rhinosinusitis
  • Most common form; symptoms include facial pain, congestion, and nasal obstruction

  • Self-limiting under 4 weeks, supportive care focus

Acute Bacterial Rhinosinusitis
  • Symptoms persist beyond initial improvement period; purulent nasal discharge is common

  • Treatment: Symptomatic management with possible antibiotics for at-risk groups (older patients, chronic conditions)

    • Amoxicillin-clavulanate established first-line therapy

Chronic Rhinosinusitis (CRS)

  • Defined as sinusitis persisting over 12 weeks

  • Categories:

    • CRS without polyps

    • CRS with polyps (more severe)

Diagnostic Criteria
  • Two or more of: nasal obstruction, nasal discharge, facial pain, or hyposmia/decreased smell

  • Imaging techniques: Typically aims for CT to confirm inflammation

Treatment Options for Chronic Sinusitis
  • Goals include managing symptoms and quality of life

  • Therapeutic approaches: Daily nasal irrigations with high-volume saline, intranasal corticosteroids as first-line therapy

  • Surgical approaches: FESS (Functional Endoscopic Sinus Surgery), balloon sinuplasty, biologic therapies for severe cases

Fungal Sinusitis

  • Risk factor: immunocompromised state; includes types such as aspergillosis and mucormycosis

  • Diagnosis and management require surgical debridement and antifungal treatment

Nasal Polyps

  • Mucosal-covered masses often linked to allergic rhinitis and AERD (Aspirin-Exacerbated Respiratory Disease)

  • Symptoms: Nasal obstruction, anosmia, secondary sinusitis

  • Treatment: Intranasal steroids and potential polypectomy if medical management fails

Neoplasms of the Nasal Cavity

  • Can be benign (e.g., nasal polyps) or malignant (e.g., nasopharyngeal tumors)

  • Risk factors include occupational exposures and tobacco use

  • Symptoms: nasal obstruction, nasal mass, and possibly weight loss

Epistaxis (Nosebleeds)

  • Definition: Acute bleeding from the nostril, nasal cavity, or nasopharynx

  • Most common cause: anterior bleeds from Kiesselbach's plexus

    • Signs include nasal congestion without rhinorrhea; potential local/systemic causes identified

Treatment of Epistaxis
  • Initial Management: Direct pressure, packing, cauterization with silver nitrate or electrocautery

  • Severe cases may mandate hospitalization, ENT consultation for surgical options

Deviated Septum

  • Causes nasal obstruction, common in trauma cases

  • Treatments: Omitting imaging unless other factors considered (e.g., complex cases); septoplasty can help relieve significant obstruction

Mucormycosis

  • A serious, opportunistic fungal infection assessing individuals with underlying immunosuppression

  • Treatment includes surgical intervention and prompt antifungal therapy

Summary of Care Recommendations

  • Symptomatic care options for acute rhinosinusitis include supportive measures emphasizing pain relief and inflammation reduction, hydration, and possible pharmacotherapy where needed.